Aurinia exists to make a difference. Our mission is to transform people's lives by delivering therapeutics that change the course of autoimmune disease. From the earliest days of the company, we've applied a creative, thoughtful and responsible approach to developing therapies for people in need.
In addition to driving adoption of our approved therapy for appropriate people with lupus nephritis, we are also actively pursuing a broader portfolio of innovative drugs for autoimmune disease.Our strategy leverages the skills and knowledge of our incredible team and our deep experience in principled drug development and commercialization.
In addition to driving adoption of our approved therapy for appropriate people with lupus nephritis, we are also actively pursuing a broader portfolio of innovative drugs for autoimmune disease.Our strategy leverages the skills and knowledge of our incredible team and our deep experience in principled drug development and commercialization.
Services
We combine decades of commitment to changing the paradigm for people living with serious diseases along with leadership in scientific innovation, drug development, commercialization and corporate strategy to realize Aurinia's mission. Peter Greenleaf currently serves as the Chief Executive Officer and member of the Board of Directors of Aurinia.
Aurinia's mission is to transform people's lives by delivering therapeutics that change the course of autoimmune disease. We believe strong collaboration powers success at every level of drug development and commercialization. We are committed to forging strategic partnerships aligned with our mission to help advance groundbreaking therapies for people in need.
We are committed to transforming people's lives by delivering therapeutics that change the course of autoimmune disease. This area includes many of the most challenging and burdensome chronic diseases for global healthcare systems, and on an individual level they often have significant impacts on quality of life.
Aurinia is committed to serve patients which includes collecting, assessing and reporting all adverse events (AEs, i.e., side effects), other safety findings, and product quality complaints (PQCs) associated with the use of Aurinia's products. To enable Aurinia to provide up-to date safety information on our products and ensure quality of our medications, your support is pivotal, whether you are a patient, consumer or healthcare provider.
Lupus nephritis is a serious and common inflammation of the kidneys caused by Systemic Lupus Erythematosus (SLE or lupus). If you have lupus, you may be at risk for developing lupus nephritis.
While lupus nephritis itself is rare among the general population, it may be more common than you think, impacting ~100K patients in the U.S., about one-third of adults have lupus nephritis at diagnosis of lupus and about 1 out of 2 people with lupus may develop lupus nephritis over time.Your kidneys play a crucial role in keeping your body healthy by removing toxic waste and excess fluid from your body through urine.
While lupus nephritis itself is rare among the general population, it may be more common than you think, impacting ~100K patients in the U.S., about one-third of adults have lupus nephritis at diagnosis of lupus and about 1 out of 2 people with lupus may develop lupus nephritis over time.Your kidneys play a crucial role in keeping your body healthy by removing toxic waste and excess fluid from your body through urine.
Reviews
Be the first to review Aurinia Pharma.
Write a Review
